Form 4: Sight Sciences CLO Sells Shares Under Marital Separation Plan
Insider Transaction Report
Sight Sciences' Chief Legal Officer, Jeremy B. Hayden, sold 3,150 shares of common stock for $8.01 per share following option exercises, with proceeds going to his former spouse as part of a marital separation agreement.
Summary
- Jeremy B. Hayden, Chief Legal Officer of Sight Sciences, Inc., executed transactions on November 12, 2025.
- The transactions involved the exercise of stock options and the subsequent sale of common stock.
- A total of 3,150 shares were acquired through option exercises at a price of $1.96 per share.
- Concurrently, 3,150 shares of common stock were sold at a weighted average price of $8.01 per share, with individual sales ranging from $8.00 to $8.06.
- These transactions were conducted under a Rule 10b5-1 trading plan, established in connection with a marital separation agreement.
- All proceeds from the sold shares will be received by Mr. Hayden's former spouse.
- Following these transactions, Mr. Hayden beneficially owns 256,590 shares of common stock and no derivative securities (options).
Sentiment
Score: 5
Explanation: The sentiment is neutral as the insider sale is explicitly attributed to a marital separation agreement and a pre-arranged 10b5-1 plan, mitigating typical negative interpretations of insider selling.
Positives
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned, rather than reactive, sale.
- The options exercised were fully vested, reflecting prior equity compensation.
Negatives
- An insider sale, even for personal reasons, can sometimes be perceived negatively by the market.
Related Party Transactions
- The transactions were executed pursuant to a marital separation agreement, with all proceeds from the sold shares going to the reporting person's former spouse.
Stakeholder Impact
- Shareholders might observe an insider sale, but the stated reason (marital separation) typically lessens concerns about management's confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 11/12/2025 | Date of earliest transaction, including stock option exercises and common stock sales. |
| 11/14/2025 | Date the Form 4 was signed by Jeremy Hayden. |
| 05/10/2030 | Expiration date for a portion of the exercised stock options. |
| 07/28/2030 | Expiration date for another portion of the exercised stock options. |
Recommendation
holdThe insider sale by the Chief Legal Officer is a personal transaction driven by a marital separation agreement and executed under a Rule 10b5-1 plan. This context suggests the sale is not indicative of a change in the officer's view of the company's prospects. Therefore, this filing alone does not warrant a change in investment recommendation, and a 'hold' stance is maintained based on existing company fundamentals.
Keywords
Sight Sciences, SGHT, Form 4, Insider Trading, Stock Option Exercise, Stock Sale, Jeremy B. Hayden, Chief Legal Officer, 10b5-1 Plan, Marital Separation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.